Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal dexmedetomidine for early postoperative cognitive function in children after general anesthesia
ChiCTR1900023335Phase 4Not yet recruiting
- Sponsor
- Maternal and Child Health Hospital of Hubei Province
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in post-operative cognitive decline (POCD) (2 arms), sponsored by Maternal and Child Health Hospital of Hubei Province. Primary endpoints: Serum S100β concentration, Serum interleukin-6 concentration and 4 more. Planned start May 2019; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR1900023335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900023335.